Sitagliptin added to treatment with ongoing pioglitazone for up to 52 weeks improves glycemic control in Japanese patients with type 2 diabetes

Aims/Introduction:  Patients with type 2 diabetes mellitus often require treatment with more than one oral antihyperglycemic agent to achieve their glycemic goal. The present study was carried out to assess the efficacy and safety of sitagliptin as add‐on therapy in Japanese patients with type 2 dia...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Kashiwagi, Atsunori, Kadowaki, Takashi, Tajima, Naoko, Nonaka, Kenji, Taniguchi, Tadaaki, Nishii, Mikio, Ferreira, Juan Camilo Arjona, Amatruda, John M
Formato: Artigo
Lenguaje:Inglês
Publicado: Blackwell Publishing Ltd 2011
Materias:
Articles
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC4019307/
https://ncbi.nlm.nih.gov/pubmed/24843518
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.2040-1124.2011.00120.x
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares